50 Mg Vinorelbine Injection IP

Name: 50 Mg Vinorelbine Injection IP
Brand: NEETCO BIOPHARMA
Price: 3000 INR
Availability: InStock

Price 3000 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

50 Mg Vinorelbine Injection IP Specification

Indication
Treatment of non-small cell lung cancer and metastatic breast cancer

Dosage Form
Injection

Salt Composition
Vinorelbine (50 mg)

Feature
Cytotoxic anticancer agent for injectable use

Ingredients
Vinorelbine tartrate, water for injection, excipients

Application
Intravenous administration

Ph Level
Typically between 3.0 - 5.0

Physical Color/Texture
Clear, colorless solution

Fermentation Smell
Odorless

Storage Instructions
Store between 2C - 8C. Protect from light.

Shelf Life
2 years from the date of manufacture

About 50 Mg Vinorelbine Injection IP

Experience the ultimate in cancer care with Vinorelbine Injection IP, a trending and superior antineoplastic solution. Each 50 mg/5 ml glass vial offers a sensational treatment option for non-small cell lung cancer and metastatic breast cancer. Explore the efficacy and safety of a prescription-only cytotoxic agent, compatible with standard intravenous infusion solutions. Conveniently supplied in an odorless, clear solution, it is recommended for single-use only. This product is widely recognized for its reliable performance, strict quality control, and preservation requirements. Offer your patients the competitive edge in cancer therapy today.

Competitive Advantages and Applications

Vinorelbine Injection IP stands out for its superior pharmacological profile and compatibility with standard IV infusion solutions. Designed for intravenous administration under medical supervision, it delivers optimal effectiveness. Dosage follows the treating physician's direction. In addition to oncology, ongoing clinical trials may explore other cancer types. The competitive advantages include reliable efficacy, enhanced safety measures, and precise dosing, making it a preferred choice for healthcare institutions and cancer treatment centers committed to best practices.

Order Fulfillment and Domestic Market Reach

With an extensive presence across India's main domestic market, we ensure swift order completion and quick dispatch of Vinorelbine Injection IP. Our superior supply ability means consistent inventory, supporting bulk needs for distributors, exporters, and suppliers. Standard delivery time is minimized through efficient logistics, providing healthcare professionals uninterrupted availability. Experience prompt delivery and responsive customer support, from order placement to shipment, guaranteeing that every vial reaches your facility in optimal condition for immediate therapeutic use.

FAQ's of 50 Mg Vinorelbine Injection IP:

Q: How should Vinorelbine Injection IP 50 mg be administered?

A: Vinorelbine Injection IP 50 mg is administered intravenously by a healthcare professional, following a prescribed dosage regimen based on the patient's condition. It should never be self-administered.

Q: What are the main uses of Vinorelbine Injection IP?

A: This injection is primarily indicated for the treatment of non-small cell lung cancer and metastatic breast cancer, offering proven antineoplastic benefits.

Q: When should the unused portion of Vinorelbine Injection IP be discarded?

A: Vinorelbine Injection IP is for single use only. Any unused portion must be discarded immediately after opening the vial to ensure patient safety.

Q: Where should Vinorelbine Injection IP be stored?

A: The product should be stored between 2C and 8C, protected from light, to maintain its quality and potency. Do not freeze.

Q: What adverse reactions may occur with Vinorelbine Injection IP?

A: Possible adverse effects include neutropenia, anemia, nausea, vomiting, and injection site reactions. Patients should be closely monitored by healthcare professionals during treatment.

Q: How does Vinorelbine Injection IP provide a competitive advantage?

A: Its compatibility with standard infusion solutions, clear pharmacokinetics, and reliable efficacy ensure superior outcomes, making it a trusted option for cancer care providers.

Tell us about your requirement